0.4676
Oncolytics Biotech Inc Borsa (ONCY) Ultime notizie
Oncolytics Biotech (ONCY) Downgraded by Jones Trading | ONCY Sto - GuruFocus
Oncolytics (ONCY) Downgraded Amid CEO Search and Capital Concerns | ONCY Stock News - GuruFocus
Oncolytics Biotech’s Earnings Call: Optimism Amid Challenges - TipRanks
Stocks in play: Oncolytics Biotech Inc - The Globe and Mail
Oncolytics Biotech Inc - Baystreet.ca
Oncolytics Biotech Inc (ONCY) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance
Oncolytics Biotech Inc (ONCY) Q1 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - GuruFocus
Oncolytics Biotech Reports Q1 Results and Clinical Progress - TipRanks
Oncolytics Biotech Reports Q1 2025 Financial Results - TipRanks
Oncolytics Biotech Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Oncolytics Biotech Reports Promising Q1 Results and Advances in Cancer Treatment - TipRanks
Breakthrough Cancer Trial: Oncolytics Achieves 33% Response Rate in Anal Cancer, Reports Strong Q1 Progress - Stock Titan
How To Trade (ONC) (ONC:CA) - news.stocktradersdaily.com
Oncolytics Biotech® to Host Conference Call to Discuss First Quarter Financial Results and Recent Operational Highlights - Kilgore News Herald
Oncolytics Biotech Inc expected to post a loss of 10 cents a shareEarnings Preview - TradingView
(ONC) Trading Strategy and Analysis (ONC:CA) - news.stocktradersdaily.com
(ONC) Stock Analysis and Trading Signals (ONC:CA) - news.stocktradersdaily.com
Oncolytics Biotech to Discuss Q1 2025 Financial Results on May 14 - TipRanks
Stocks In Play: Oncolytics Biotech® Inc. By Baystreet.ca - Investing.com Canada
Oncolytics Biotech® Inc. - Baystreet.ca
Stocks in play: Oncolytics Biotech® Inc. - The Globe and Mail
Oncolytics Biotech to Discuss Q1 Financial Results and Operational Highlights - TipRanks
Oncolytics Biotech® to Host Conference Call to Discuss First Qua - GuruFocus
Oncolytics Biotech® to Host Conference Call to Discuss First Quarter Financial Results and Recent Operational Highlights | ONCY Stock News - GuruFocus
(ONC) Risk-Controlled Trading Report (ONC:CA) - news.stocktradersdaily.com
Oncolytics Biotech(R) and PrECOG Announce Collaboration for BRACELET-1 (PrE0113) Study in Metastatic Breast Cancer - ACCESS Newswire
(ONC) Technical Data (ONC:CA) - news.stocktradersdaily.com
New Cancer Treatments Spark Hope as Traditional Funding Faces Uncertainty - Longview News-Journal
Oncolytics Biotech, Inc. to Host Earnings Call - ACCESS Newswire
(ONC) Technical Patterns and Signals (ONC:CA) - news.stocktradersdaily.com
Press Release Distribution & PR Platform - ACCESS Newswire
Why the Global Cancer Market Could Surpass $900 Billion--And the Stocks Leading the Charge - ADVFN
(ONC) Stock Trading Blueprint (ONC:CA) - news.stocktradersdaily.com
Small-cap cancer therapy innovator raises $20M in flexible funding - MSN
Stocks In Play: Oncolytics Biotech Inc - Barchart.com
Oncolytics to Present New Pancreatic Cancer Data at Oncology Meeting Next Month - marketscreener.com
Oncolytics Biotech® to Showcase New Pancreatic Cancer Data at AS - GuruFocus
Oncolytics Biotech to Present Promising Pancreatic Cancer Data at ASCO 2025 - TipRanks
Oncolytics Biotech® to Showcase New Pancreatic Cancer Data at ASCO Highlighting Pelareorep's Tumor-Fighting Mechanism of Action - Barchart.com
(ONC) Long Term Investment Analysis (ONC:CA) - news.stocktradersdaily.com
Investors Eye Biotech Sector as Cancer Therapy Market Surges (PR Newswire) - Aktiellt
Oncology Breakthroughs: How Cancer Research Is Advancing in 2025 (PR Newswire) - Aktiellt
Buzz on the Bullboards: Energy, cannabis, and Biotech Shine on the TSX | 2025-04-17 | Investing News - Stockhouse
Oncolytics Biotech® to Host Conference Call to Discuss Third Quarter Financial Results and Recent Operational Highlights - Quantisnow
(ONC) Investment Performance Report (ONC:CA) - news.stocktradersdaily.com
Oncolytics Biotech : reg; Doses First Patient in Phase 2 BRACELET-1 Study Evaluating Pelareorep-Based Combination Therapies in Metastatic Breast Cancer - marketscreener.com
Oncolytic Virus Therapy Market Size, Share and Strategic - openPR.com
With Young Adult Cancer on the Rise, New Therapies Spark Investor Buzz - The Malaysian Reserve
As Cancer Rates Climb, Wall Street Turns Its Gaze Toward New Frontiers in Cancer Treatments - Baystreet.ca
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):